IL-21 NK Cells Demonstrate Anti-Tumor Potential Against Glioblastoma

IL-21-expressing NK cells demonstrate sustained anti-tumor activity against glioblastoma stem cell-like cells (GSCs). Both in vitro and in vivo experiments confirm this effect, bringing new breakthroughs in glioblastoma treatment. These findings suggest that IL-21-modified NK cell therapy may represent a promising immunotherapeutic approach for patients with glioblastoma.

Medical Supporter was formerly certified as an international medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).

Figure 1

Figure 2

Figure 3

Figure 4